239 related articles for article (PubMed ID: 9764148)
1. The use of skin testing in the investigation of cutaneous adverse drug reactions.
Barbaud A; Reichert-Penetrat S; Tréchot P; Jacquin-Petit MA; Ehlinger A; Noirez V; Faure GC; Schmutz JL; Béné MC
Br J Dermatol; 1998 Jul; 139(1):49-58. PubMed ID: 9764148
[TBL] [Abstract][Full Text] [Related]
2. [Skin tests in the study of drug eruptions with suspected immuno-allergic mechanism].
Barbaud A; Béné MC; Faure G; Schmutz JL
Bull Acad Natl Med; 2000; 184(4):775-91. PubMed ID: 10989563
[TBL] [Abstract][Full Text] [Related]
3. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon?
Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó
Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions.
Barbaud A; Gonçalo M; Bruynzeel D; Bircher A;
Contact Dermatitis; 2001 Dec; 45(6):321-8. PubMed ID: 11846746
[TBL] [Abstract][Full Text] [Related]
5. Skin tests in the diagnosis of eruptions caused by betalactams.
Lisi P; Lapomarda V; Stingeni L; Assalve D; Hansel K; Caraffini S; Agostinelli D
Contact Dermatitis; 1997 Oct; 37(4):151-4. PubMed ID: 9385509
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of skin test reactions in patients with non-immediate type drug eruptions.
Osawa J; Naito S; Aihara M; Kitamura K; Ikezawa Z; Nakajima H
J Dermatol; 1990 Apr; 17(4):235-9. PubMed ID: 2142173
[TBL] [Abstract][Full Text] [Related]
7. [The use of skin testing in the investigation of toxidermia: from pathophysiology to the results of skin testing].
Barbaud A
Therapie; 2002; 57(3):258-62. PubMed ID: 12422538
[TBL] [Abstract][Full Text] [Related]
8. Is drug allergy less prevalent than previously assumed? A 5-year analysis.
Heinzerling LM; Tomsitz D; Anliker MD
Br J Dermatol; 2012 Jan; 166(1):107-14. PubMed ID: 21916887
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of skin tests to prove drug hypersensitivity.
Lammintausta K; Kortekangas-Savolainen O
Br J Dermatol; 2005 May; 152(5):968-74. PubMed ID: 15888154
[TBL] [Abstract][Full Text] [Related]
10. Non-immediate Cutaneous Reactions to Beta-Lactams: Approach to Diagnosis.
Romano A; Valluzzi RL; Caruso C; Maggioletti M; Gaeta F
Curr Allergy Asthma Rep; 2017 Apr; 17(4):23. PubMed ID: 28382604
[TBL] [Abstract][Full Text] [Related]
11. Skin testing in delayed reactions to drugs.
Barbaud A
Immunol Allergy Clin North Am; 2009 Aug; 29(3):517-35. PubMed ID: 19563995
[TBL] [Abstract][Full Text] [Related]
12. Drug patch testing in systemic cutaneous drug allergy.
Barbaud A
Toxicology; 2005 Apr; 209(2):209-16. PubMed ID: 15767038
[TBL] [Abstract][Full Text] [Related]
13. Allergy to beta-lactam antibiotics in children.
Ponvert C; Le Clainche L; de Blic J; Le Bourgeois M; Scheinmann P; Paupe J
Pediatrics; 1999 Oct; 104(4):e45. PubMed ID: 10506270
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous adverse drug reaction to oral acetazolamide and skin tests.
Jachiet M; Bellon N; Assier H; Amsler E; Gaouar H; Pecquet C; Bourrain JL; Bégon E; Chosidow O; Francès C; Ingen-Housz-Oro S; Soria A
Dermatology; 2013; 226(4):347-52. PubMed ID: 23817276
[TBL] [Abstract][Full Text] [Related]
15. The role of penicillin in benign skin rashes in childhood: a prospective study based on drug rechallenge.
Caubet JC; Kaiser L; Lemaître B; Fellay B; Gervaix A; Eigenmann PA
J Allergy Clin Immunol; 2011 Jan; 127(1):218-22. PubMed ID: 21035175
[TBL] [Abstract][Full Text] [Related]
16. Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions.
Waton J; Tréchot P; Loss-Ayav C; Schmutz JL; Barbaud A
Br J Dermatol; 2009 Apr; 160(4):786-94. PubMed ID: 19120340
[TBL] [Abstract][Full Text] [Related]
17. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions.
Barbaud A; Trechot P; Reichert-Penetrat S; Commun N; Schmutz JL
Contact Dermatitis; 2001 Nov; 45(5):265-8. PubMed ID: 11722484
[TBL] [Abstract][Full Text] [Related]
18. Value of patch tests in clindamycin-related drug eruptions.
Pereira N; Canelas MM; Santiago F; Brites MM; Gonçalo M
Contact Dermatitis; 2011 Oct; 65(4):202-7. PubMed ID: 21689110
[TBL] [Abstract][Full Text] [Related]
19. Skin tests in the diagnosis of adverse drug reactions.
Stingeni L; Bianchi L; Tramontana M; Pigatto PD; Patruno C; Corazza M; Foti C; Fabbrocini G; Micali G; Romita P; Napolitano M; Hansel K
G Ital Dermatol Venereol; 2020 Oct; 155(5):602-621. PubMed ID: 32938165
[TBL] [Abstract][Full Text] [Related]
20. [Drug patch tests in the investigation of cutaneous adverse drug reactions].
Barbaud A
Ann Dermatol Venereol; 2009; 136(8-9):635-44. PubMed ID: 19686903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
